Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease

Journal Article Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease Get access Shinji Sato, Shinji Sato Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, 142 Shimokasuya, Isehara 160-8582, Japan Correspondence to: Shinji Sato, Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, 142 Shimokasuya, Isehara 160-8582, Japan e-mail: shinsjam@tokai-u.jp Search for other works by this author on: Oxford Academic Google Scholar Masataka Kuwana, Masataka Kuwana Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan Search for other works by this author on: Oxford Academic Google Scholar Takashi Fujita, Takashi Fujita Laboratory of Molecular Genetics, Institute for Virus Research Kyoto University, 53 Shogoin-kawaharacho, Sakyo-ku, Kyoto 606-8507, Japan Search for other works by this author on: Oxford Academic Google Scholar Yasuo Suzuki Yasuo Suzuki Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, 142 Shimokasuya, Isehara 160-8582, Japan Search for other works by this author on: Oxford Academic Google Scholar Modern Rheumatology, Volume 23, Issue 3, 1 May 2013, Pages 496–502, https://doi.org/10.3109/s10165-012-0663-4 Published: 01 May 2013 Article history Received: 07 March 2012 Accepted: 01 May 2012 Published: 01 May 2013